Technology | 2017.02.06
BioVentrix Announces NUB Reimbursement Status 1 for Revivent TC™ TransCatheter Ventricular Enhancement System in Germany
SAN RAMON, Calif., Feb. 6, 2017 /PRNewswire/ -- BioVentrix, Inc. a pioneer of technologies and procedures for less invasive treatment of heart failure (HF), today announced that InEk, the German Institute for the Hospital Remuneration System, has awarded NUB Status 1 for the Revivent TC™...
For more information, please visit
http://www.prnewswire.com/news-releases/[...]stem-in-germany-300401781.html
